AACR-Kids Beating Cancer Margaret Guedes Monosomy 7 Legacy Cancer Research Grant
AACR-Kids Beating Cancer Margaret Guedes Monosomy 7 Legacy Cancer Research Grant supports investigators studying monosomy 7 and related high-risk AML to improve treatment, address relapse, and enhance survivorship.
Browse similar grants
Funder: American Association for Cancer Research
Due Dates: December 1, 2026, at 1:00 p.m. U.S. Eastern Time (Application) | February 2027 (Award notification) | April 1, 2027 (Grant start)
Funding Amounts: $300,000 USD over three years
Summary: Supports innovative research addressing monosomy 7 AML and other rare, high-risk cytogenetic AML subtypes to improve treatment and patient outcomes.
Key Information: Applicants must be independent investigators and meet AACR Active Membership requirements by submission.
Description
This partnership between Kids Beating Cancer and the American Association for Cancer Research (AACR) supports innovative research on monosomy 7 acute myeloid leukemia (AML) and related rare, high-risk cytogenetic subtypes. These aggressive diseases are associated with treatment resistance, relapse, and limited long-term survival. The grant aims to advance biological understanding, identify therapeutic vulnerabilities, improve response assessment, address relapse, and enhance survivorship.
Projects may span basic, translational, clinical, and population sciences. They must address critical unmet needs and offer a clear rationale for improving diagnosis, risk stratification, therapeutic targeting, treatment response prediction, survivorship, or durable remission. Applications are welcomed from investigators already studying these diseases and researchers bringing promising approaches from other cancer or biomedical fields.
